Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,147 INR | -0.40% | -0.31% | +5.93% |
May. 02 | Aurobindo Pharma Completes Sale of US Arm's Business Assets | MT |
Apr. 07 | Aurobindo Pharma Limited Announces Appointment of T. Vijaya Kumar as President R&D (Specialty Drug Delivery) | CI |
Sales 2024 * | 287B 3.44B | Sales 2025 * | 314B 3.77B | Capitalization | 675B 8.09B |
---|---|---|---|---|---|
Net income 2024 * | 31.44B 377M | Net income 2025 * | 37.86B 454M | EV / Sales 2024 * | 2.29 x |
Net cash position 2024 * | 18.34B 220M | Net cash position 2025 * | 35.81B 429M | EV / Sales 2025 * | 2.03 x |
P/E ratio 2024 * |
21.5
x | P/E ratio 2025 * |
17.8
x | Employees | 23,451 |
Yield 2024 * |
0.35% | Yield 2025 * |
0.43% | Free-Float | 47.93% |
Latest transcript on Aurobindo Pharma
1 day | -0.47% | ||
1 week | -0.49% | ||
Current month | -0.63% | ||
1 month | +2.32% | ||
3 months | +12.99% | ||
6 months | +31.17% | ||
Current year | +5.74% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 66 | 86-12-25 | |
Director of Finance/CFO | - | 12-12-31 | |
B. Adi Reddy
CMP | Compliance Officer | - | 16-05-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Founder | 66 | 86-12-25 | |
Founder | 66 | 86-12-25 | |
Director/Board Member | 64 | 03-05-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.32% | 6 M€ | +6.07% | - | |
0.22% | 18 M€ | +6.49% | ||
0.12% | 11 M€ | +4.66% |
Date | Price | Change | Volume |
---|---|---|---|
24-05-06 | 1,147 | -0.40% | 200 130 |
24-05-03 | 1,152 | -0.41% | 802,670 |
24-05-02 | 1,156 | +0.25% | 713,707 |
24-04-30 | 1,154 | +0.15% | 2,442,943 |
24-04-29 | 1,152 | +1.81% | 2,471,250 |
Delayed Quote NSE India S.E., May 05, 2024 at 11:57 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+5.74% | 8.09B | |
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B |
- Stock Market
- Equities
- AUROPHARMA Stock